BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23410560)

  • 21. Dermatomyositis and Graves' disease.
    Selva-O'Callaghan A; Mijares-Boeckh-Behrens T; Solans-Laque R; Molins-Vara T; Olivé G; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2001; 19(5):595-6. PubMed ID: 11579725
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithyroid drugs in practice.
    Vanderlaan WP
    Mayo Clin Proc; 1972 Dec; 47(12):962-5. PubMed ID: 4117991
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
    Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
    Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Graves' Disease Accompanied with Acute Hepatitis A Virus Infection.
    Hong SE; Choo JW; Lim SK; Lee SJ; Park JW; Kim SE; Kim JH; Park CK
    Korean J Gastroenterol; 2018 Jun; 71(6):354-358. PubMed ID: 29943563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
    Suzuki S; Takei M; Nishio S; Inaba H; Sato A; Yamazaki M; Shinomiya K; Hashizume K
    Horm Metab Res; 2009 Jul; 41(7):548-53. PubMed ID: 19280551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymic enlargement in two cases of Graves' disease.
    Nakamura S
    Intern Med; 2012; 51(6):673-4. PubMed ID: 22449686
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression of Graves' hyperthyroidism--still an elusive goal.
    Wiersinga WM
    N Engl J Med; 1996 Jan; 334(4):265-6. PubMed ID: 8532007
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thymic hyperplasia in a patient with Graves' disease].
    García E; García-Hierro V; Pilar Alvarez M; de la Maza L; Santos E; Pi J; Castillo L; Ruiz E
    Endocrinol Nutr; 2009 Feb; 56(2):92-5. PubMed ID: 19627717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marine-Lenhart syndrome in a young girl.
    Şen Y; Cimbek EA; Yuca SA; Gedik GK; Sarı O
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):189-91. PubMed ID: 24057592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood onset demyelination and Graves' disease: shared antigen or autoimmune clustering?
    Mitchell RS; Yager JY; Marks SD
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1233-6. PubMed ID: 18183795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atypical subacute thyroiditis in combination with Grave's disease:Diagnostic difficulties in a case report].
    Koutouridou E; Planck T; Uddman E; Lantz M
    Lakartidningen; 2018 Apr; 115():. PubMed ID: 29664539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithyroid Drugs-The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study.
    Brito JP; Schilz S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Montori VM
    Thyroid; 2016 Aug; 26(8):1144-5. PubMed ID: 27267495
    [No Abstract]   [Full Text] [Related]  

  • 38. Unusual problems in the management of hyperthyroid Graves' disease.
    Steenkamp DW; Junqueira A; Braverman LE
    Endocr Pract; 2013; 19(1):162-5. PubMed ID: 23435045
    [No Abstract]   [Full Text] [Related]  

  • 39. Case records of the Massachusetts General Hospital. Case 10-2015. A 15-year-old girl with Graves’ disease and psychotic symptoms.
    Hazen EP; Sherry NA; Parangi S; Rabito CA; Sadow PM
    N Engl J Med; 2015 Mar; 372(13):1250-8. PubMed ID: 25806918
    [No Abstract]   [Full Text] [Related]  

  • 40. Surgical Intervention for Medically Refractory Hyperthyroidism.
    Knollman PD; Giese A; Bhayani MK
    Pediatr Ann; 2016 May; 45(5):e171-5. PubMed ID: 27171805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.